220 related articles for article (PubMed ID: 19953931)
1. [Expression and significance of CD147 protein in prostate cancer].
He HC; Han ZD; Dai QS; Zou J; Zhang Y; Zhang Z; Liang YX; Ye YK; Chen ZN; Zhong WD
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1844-6. PubMed ID: 19953931
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages.
Wang Q; Zhang JG; Wang W
Genet Mol Res; 2015 Jun; 14(2):6844-51. PubMed ID: 26125892
[TBL] [Abstract][Full Text] [Related]
3. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
4. CD147 expression indicates unfavourable prognosis in prostate cancer.
Han ZD; Bi XC; Qin WJ; He HC; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Chen ZN; Zhong WD
Pathol Oncol Res; 2009 Sep; 15(3):369-74. PubMed ID: 19048397
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
6. [Expression of glycoprotein non-metastatic melanoma protein B in prostate cancer and its significance].
Xiao YB; Qiao ZG; Zhang XW; Liu ZH; Xie J; Hao YC; Yu WD; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):496-9. PubMed ID: 21844952
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging.
Lee CT; Oesterling JE
Semin Surg Oncol; 1995; 11(1):23-35. PubMed ID: 7538692
[TBL] [Abstract][Full Text] [Related]
10. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
13. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer].
Zhou LQ; Yang XZ; Zeng L; Liang LL; Yang XY; Ren L; Chung L; Zhang ZW; Na YQ; Gu FL; Guo YL
Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):93-5. PubMed ID: 12783666
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of overexpression of Golgi membrane protein 1 in prostate cancer.
Li W; Wang X; Li B; Lu J; Chen G
Urology; 2012 Oct; 80(4):952.e1-7. PubMed ID: 22840862
[TBL] [Abstract][Full Text] [Related]
17. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy.
Grupp K; Höhne TS; Prien K; Hube-Magg C; Tsourlakis MC; Sirma H; Pham T; Heinzer H; Graefen M; Michl U; Simon R; Wilczak W; Izbicki J; Sauter G; Minner S; Schlomm T; Steurer S
Exp Mol Pathol; 2013 Oct; 95(2):227-34. PubMed ID: 23948277
[TBL] [Abstract][Full Text] [Related]
18. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
Vorobĭova LR
Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
20. [Prostatic markers, today and tomorrow].
Terrone C; Faraone N; Aimo G; Priolo G
Recenti Prog Med; 2000 Nov; 91(11):576-80. PubMed ID: 11125951
[No Abstract] [Full Text] [Related]
[Next] [New Search]